VaramirStart free · no cardSign in
RLAY as of Oct 31 · 14:22 ET
RLAYNasdaqBiological Products, (No Diagnostic Substances)

Relay Therapeutics, Inc. · Brief

Next report

5 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±26.4%
avg realized
±6.0%
Nov 6 '24±22.9%▼−1.76%×0.08
Feb 26 '25±32.5%▼−13.33%×0.41
May 5 '25±17.6%▼−5.12%×0.29
Aug 7 '25±33.6%▼−7.74%×0.23
Q3 FY25±32.5%▼−7.35%×0.23
Q1 FY26±40.7%▲+12.01%×0.30
May 5 '26±14.2%▼−0.62%×0.04
Q2 FY26±17.0%▲+0.10%×0.01
quarterimplied−45%0+45%realized×
Q2 FY26±17.0%▲+0.10%×0.01
May '26±14.2%▼−0.62%×0.04
Q1 FY26±40.7%▲+12.01%×0.30
Q3 FY25±32.5%▼−7.35%×0.23
Aug '25±33.6%▼−7.74%×0.23
May '25±17.6%▼−5.12%×0.29
2 older reports
Feb '25±32.5%▼−13.33%×0.41
Nov '24±22.9%▼−1.76%×0.08
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 4

3disclosed supplier and customer ties in SEC filingsSEC filings
4tracked funds holding RLAYN-PORT · Aug 31 '26

Bear2 of 4

8 of 8recent reports where the move came in under the options implied rangeEarnings history
1.10%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

RLAY report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±13.9% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.